机构:[1]Department of Urology, West China Hospital, Sichuan University,Chengdu, 610041, China四川大学华西医院[2]Institute of Urology, West China Hospital, Sichuan University,Chengdu, 610041, China四川大学华西医院
第一作者机构:[1]Department of Urology, West China Hospital, Sichuan University,Chengdu, 610041, China[2]Institute of Urology, West China Hospital, Sichuan University,Chengdu, 610041, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Urology, West China Hospital, Sichuan University,Chengdu, 610041, China[2]Institute of Urology, West China Hospital, Sichuan University,Chengdu, 610041, China[*1]Institute of Urology, Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
推荐引用方式(GB/T 7714):
Wang Sheng,Xu Hang,Ai Jianzhong,et al.BRCA mutation status with poly (ADP-ribose) polymerase inhibitor efficacy in cancer: A systematic review and meta-analysis[J].Asian journal of surgery.2023,doi:10.1016/j.asjsur.2023.07.118.
APA:
Wang Sheng,Xu Hang,Ai Jianzhong&Yang Lu.(2023).BRCA mutation status with poly (ADP-ribose) polymerase inhibitor efficacy in cancer: A systematic review and meta-analysis.Asian journal of surgery,,
MLA:
Wang Sheng,et al."BRCA mutation status with poly (ADP-ribose) polymerase inhibitor efficacy in cancer: A systematic review and meta-analysis".Asian journal of surgery .(2023)